International Scholarly Research Notices / 2012 / Article / Tab 1

Research Article

Investigation of Tenascin Expression in Endometriosis

Table 1

Serum and tissue levels of tenascin.

Group 1
( )
Group 2
( )
value

Serum tenascin (ng/mL)
(i) Proliferative phase41 ± 738 ± 8.50.73
(ii) Secretory phase39 ± 936 ± 90.95
Eutopic endometrial tenascin
(pg/mg)
(i) Proliferative phase30 ± 933 ± 140.93
(ii) Secretory phase319 ± 109311 ± 1270.71
Ectopic endometrial tenascin
(pg/mg)
(i) Proliferative phase32 ± 11
(ii) Secretory phase285 ± 100

Note: The results are presented as mean ± SD.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.